Autologous fibroblasts as potential vehicle for regional ovarian cancer gene therapy

Advances in Experimental Medicine and Biology

Volumn 451, Issue , 1998, Pages 331-334

  Sanches, R ^a   D'Incan, C ^a   Kuiper, M ^a   Penault Llorca, F ^a   Monceau, S ^b   Bignon, Y J ^a  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; DNA SEQUENCE; FEMALE; FIBROBLAST CULTURE; GENE THERAPY; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS;

EID: 0031785546     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5357-1_51     Document Type: Article

References (11)

1. AR Miller, WH McBridge, K Hunt, JS Economou, 1994: Cytokine-mediated gene therapy for cancer. Ann. Surg. Oncol. 1, 436-450
2. MP Colombo, G Forni, 1994: Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?. Immunol. Today 15, 48-51
3. PT Golumbek, AJ Lazenby, HI Levitsky, LM Jaffee, H Karasuyama, M Baker, DM Pardoll, 1991: Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254, 713-716
4. J Connor, R Bannerji, S Saito, W Heston, W Fair, E Gilboa, 1993: Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells. J. Exp. Med. 177, 1127-1134
5. H Tahara, L Zitvogel, WJ Storkus, HJ Zeh, TG McKinney, RD Schreiber, U Gubler, PD Robbins, MT Lotze, 1995: Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol. 154, 6466-6474
6. T Marcel, JD Grausz, 1997: The TMC worldwide gene therapy enrollment report, end 1996. Hum. Gene Then 8, 775-800
7. H Tahara, HJ Zeh, WJ Storkus, I Pappo, SC Watkins, U Gubler, SF Wolf, PD Robbins, MT Lotze, 1994: Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res. 54, 182-189
8. DL Shawler, O Dorigo, RA Gjerset, I Royston, RE Sobol, H Fakhrai, 1995: Comparison of gene therapy with interleukin-2 gene modified fibroblasts and tumor cells in the murine CT-26 model of colorectal carcinoma. J. Immunother. 17, 201-208
9. H Tahara, MT Lotze, PD Robbins, WJ Storkus, L Zitvogel, 1995: IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts. Hum. Gene Ther. 6, 1607-1624
10. O Danos, RC Mulligan, 1988: Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 85, 6460-6464
11. + cells purified from peripheral blood of breast cancer patients primed with chemotherapy and granulocyte-macrophage colony-stimulating factor. Hum. Gene Ther. 5, 203-208